In the last trading session, 1.03 million Quipt Home Medical Corp (NASDAQ:QIPT) shares changed hands as the company’s beta touched 0.43. With the company’s per share price at $2.16 changed hands at $0.16 or 8.00% during last session, the market valuation stood at $93.83M. QIPT’s last price was a discount, traded about -88.43% off its 52-week high of $4.07. The share price had its 52-week low at $1.35, which suggests the last value was 37.5% up since then. When we look at Quipt Home Medical Corp’s average trading volume, we note the 10-day average is 0.69 million shares, with the 3-month average coming to 878.49K.
Analysts gave the Quipt Home Medical Corp (QIPT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.50. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended QIPT as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Quipt Home Medical Corp’s EPS for the current quarter is expected to be 0.
Quipt Home Medical Corp (NASDAQ:QIPT) trade information
Instantly QIPT was in green as seen at the end of in last trading. With action 24.86%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -29.18%, with the 5-day performance at 24.86% in the green. However, in the 30-day time frame, Quipt Home Medical Corp (NASDAQ:QIPT) is 0.93% up. Looking at the short shares, we see there were 1.63 million shares sold at short interest cover period of 11.29 days.
The consensus price target for the stock as assigned by Wall Street analysts is 1.7, meaning bulls need a downside of -27.06% from its current market value. According to analyst projections, QIPT’s forecast low is 1.7 with 1.7 as the target high. To hit the forecast high, the stock’s price needs a 21.3% surge from its current level, while the stock would need to tank 21.3% for it to hit the projected low.
Quipt Home Medical Corp (QIPT) estimates and forecasts
Year-over-year growth is forecast to reach -6.42% down from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 80.37M. 2 analysts are of the opinion that Quipt Home Medical Corp’s revenue for the current quarter will be 81.29M. The company’s revenue for the corresponding quarters a year ago was 87.63M and 87.3M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -8.29%. The estimates for the next quarter sales put growth at -6.88%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 13.26%. The 2025 estimates are for Quipt Home Medical Corp earnings to increase by 16.06%, but the outlook for the next 5-year period is at -4.06% per year.
QIPT Dividends
Quipt Home Medical Corp is expected to release its next quarterly earnings report on 2025-Feb-09.
Quipt Home Medical Corp (NASDAQ:QIPT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 15.25% of Quipt Home Medical Corp shares while 56.42% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 66.57%. There are 56.42% institutions holding the Quipt Home Medical Corp stock share, with CLARET ASSET MANAGEMENT CORP the top institutional holder. As of 2024-06-30, the company held 10.7083% of the shares, roughly 4.56 million QIPT shares worth $14.71 million.
FORAGER CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 5.5345% or 2.36 million shares worth $7.6 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were World Funds Trust-Philotimo Focused Growth and Income Fund and ROYCE FUND-Royce Small-Cap Opportunity Fund . With 1.66 shares estimated at $3.57 million under it, the former controlled 3.80% of total outstanding shares. On the other hand, ROYCE FUND-Royce Small-Cap Opportunity Fund held about 2.39% of the shares, roughly 1.04 shares worth around $2.24 million.
